Immunomedics Inc (IMMU) 2.65 $IMMU
IMPORTANT SHAREHOLDER NOTICE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Immunomedics Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Fri Jul 29, 10:11AM CDT
IRVINE, CA / ACCESSWIRE / July 29, 2016 / Khang & Khang LLP (the "Firm"
announces that a class action lawsuit was filed against Immunomedics Inc. ("Immunomedics" or the "Company" (NASDAQ: IMMU). Investors who purchased or otherwise acquired shares between April 20, 2016 and June 2, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the August 8, 2016, lead plaintiff motion deadline.
IMMU: 2.65 (+0.04)
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Immunomedics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 8, 2016
BusinessWire - Fri Jul 29, 8:35AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
IMMU: 2.65 (+0.04)
Brower Piven Alerts Shareholders of Upcoming Deadline in Class Action Lawsuit and Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Immunomedics, Inc. to Contact the Firm - IMMU
GlobeNewswire - Thu Jul 28, 2:45PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Immunomedics, Inc. (Nasdaq:IMMU) ("Immunomedics" or the "Company" securities during the period between April 20, 2016 and June 3, 2016, inclusive (the "Class Period". Investors with losses in excess of $100,000 who wish to become proactively involved in the litigation have until August 8, 2016 to seek appointment as lead plaintiff.
IMMU: 2.65 (+0.04)
IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Immunomedics Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Tue Jul 26, 10:53AM CDT
LOS ANGELES, CA / ACCESSWIRE / July 26, 2016 / Lundin Law PC (the "Firm" announces that a class action lawsuit was filed against Immunomedics Inc. ("Immunomedics" or the "Company" (NASDAQ: IMMU) concerning possible violations of federal securities laws between April 20, 2016 and June 2, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the August 8, 2016 lead plaintiff motion deadline.
IMMU: 2.65 (+0.04)
DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of a Class Action against Immunomedics Inc. (IMMU) and Lead Platintiff Deadline: August 8, 2016
ACCESSWIRE - Tue Jul 26, 9:24AM CDT
NEW YORK, NY / ACCESSWIRE / July 26, 2016 / Bronstein, Gewirtz & Grossman, LLC, reminds investors of class action against Immunomedics, Inc. ("Immunomedics" or the "Company" (NASDAQ-GM: IMMU). The class action has been filed in the United States District Court, District of New Jersey, on behalf of a class consisting of all persons or entities who purchased Immunomedics common stock between April 20, 2016 and June 2, 2016 inclusive (the "Class Period".
IMMU: 2.65 (+0.04)
SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Immunomedics, Inc. and a Lead Plaintiff Deadline of August 8, 2016 - IMMU
BusinessWire - Mon Jul 25, 9:24AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of New Jersey on behalf of investors who purchased Immunomedics, Inc. (NASDAQ: IMMU) securities between April 20, 2016 and June 2, 2016.
IMMU: 2.65 (+0.04)
INVESTOR NOTICE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Immunomedics Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Mon Jul 25, 4:49AM CDT
IRVINE, CA / ACCESSWIRE / July 25, 2016 / Khang & Khang LLP (the "Firm" announces that a class action lawsuit was filed against Immunomedics Inc. ("Immunomedics" or the "Company" (NASDAQ: IMMU). Investors who purchased or otherwise acquired shares between April 20, 2016 and June 2, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the August 8, 2016, lead plaintiff motion deadline.
IMMU: 2.65 (+0.04)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Immunomedics, Inc. of Class Action Lawsuit and Upcoming Deadline - IMMU
GlobeNewswire - Sun Jul 24, 8:00AM CDT
Pomerantz LLP announces that a class action lawsuit has been filed against Immunomedics, Inc. ("Immunomedics" or the "Company" (NASDAQ:IMMU) and certain of its officers. The class action, filed in United States District Court, District of New Jersey, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired Immunomedics securities between April 20, 2016 and June 2, 2016 inclusive (the "Class Period". This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act".
IMMU: 2.65 (+0.04)
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Immunomedics, Inc. - IMMU
GlobeNewswire - Mon Jul 18, 5:33PM CDT
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Immunomedics, Inc. securities (NASDAQ:IMMU) from April 20, 2016 through June 2, 2016, both dates inclusive (the "Class Period". The lawsuit seeks to recover damages for Immunomedics investors under the federal securities laws.
IMMU: 2.65 (+0.04)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Immunomedics, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 8, 2016
BusinessWire - Fri Jul 15, 8:15AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
IMMU: 2.65 (+0.04)
IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against Immunomedics Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Thu Jul 14, 12:11PM CDT
IRVINE, CA / ACCESSWIRE / July 14, 2016 / Khang & Khang LLP (the "Firm" announces that a class action lawsuit has been filed against Immunomedics Inc. ("Immunomedics" or the "Company" (NASDAQ: IMMU). Investors who purchased or otherwise acquired shares between April 20, 2016 and June 2, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the August 8, 2016 lead plaintiff motion deadline.
IMMU: 2.65 (+0.04)
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of a Class Action against Immunomedics Inc. (IMMU) and Lead Platintiff Deadline August 8, 2016
ACCESSWIRE - Thu Jul 14, 9:20AM CDT
NEW YORK, NY / ACCESSWIRE / July 14, 2016 / Bronstein, Gewirtz & Grossman, LLC, notifies investors of a class action against Immunomedics, Inc. ("Immunomedics" or the "Company" (NASDAQ-GM: IMMU). The class action has been filed in the United States District Court, District of New Jersey, on behalf of a class consisting of all persons or entities who purchased Immunomedics common stock between April 20, 2016 and June 2, 2016 inclusive (the "Class Period".
IMMU: 2.65 (+0.04)
INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Immunomedics Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Mon Jul 11, 12:16PM CDT
LOS ANGELES, CA / ACCESSWIRE / July 11, 2016 / Lundin Law PC announces a class action lawsuit has been filed against Immunomedics Inc. ("Immunomedics" or the "Company" (NASDAQ: IMMU) concerning possible violations of federal securities laws between April 20, 2016 and June 3, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the August 8, 2016 lead plaintiff motion deadline.
IMMU: 2.65 (+0.04)
IMMUNOMEDICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Immunomedics Inc. - IMMU
PR Newswire - Fri Jul 08, 9:07PM CDT
Kahn Swick & Foti, LLC ("KSF" and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until August 8, 2016 to file lead plaintiff applications in a securities class action lawsuit against Immunomedics Inc. (NasdaqGM: IMMU), if they purchased the Company's securities between April 20, 2016 and June 2, 2016, inclusive (the "Class Period". This action is pending in the United States District Court for the District of New Jersey.
IMMU: 2.65 (+0.04)
IMPORTANT SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit Against Immunomedics Inc. And Reminds Investors With Losses To Contact The Firm
ACCESSWIRE - Thu Jul 07, 7:55PM CDT
LOS ANGELES, CA / ACCESSWIRE / July 7, 2016 / Lundin Law PC announces a class action lawsuit has been filed against Immunomedics Inc. ("Immunomedics" or the "Company" (Nasdaq: IMMU) concerning possible violations of federal securities laws between April 20, 2016 and June 3, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the August 8, 2016 lead plaintiff motion deadline.
IMMU: 2.65 (+0.04)
SHAREHOLDER ALERT: Rosen Law Firm Reminds Immunomedics, Inc. Investors of Important Deadline in Class Action - IMMU
BusinessWire - Thu Jun 23, 2:34PM CDT
Rosen Law Firm, a global investor rights law firm, reminds purchasers of Immunomedics, Inc. securities (NASDAQ:IMMU) from April 20, 2016 through June 2, 2016, both dates inclusive (the "Class Period" of the important August 8, 2016 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Immunomedics investors under the federal securities laws.
IMMU: 2.65 (+0.04)
DEADLINE ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Immunomedics Inc. and Reminds Investors with Losses to Contact the Firm
BusinessWire - Thu Jun 23, 4:30AM CDT
Lundin Law PC announces a class action lawsuit has been filed against Immunomedics Inc. ("Immunomedics" or the "Company" (Nasdaq: IMMU) concerning possible violations of federal securities laws between April 20, 2016 and June 3, 2016. Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the August 8, 2016, lead plaintiff motion deadline.
IMMU: 2.65 (+0.04)
IMMUNOMEDICS, INC. INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
BusinessWire - Mon Jun 20, 4:52PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Immunomedics, Inc. (Nasdaq: IMMU) ("Immunomedics" or the "Company" securities during the period between April 20, 2016 and June 3, 2016, inclusive (the "Class Period". Investors with losses in excess of $100,000 who wish to become proactively involved in the litigation have until August 8, 2016 to seek appointment as lead plaintiff.
IMMU: 2.65 (+0.04)
IMPORTANT SHAREHOLDER NOTICE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Immunomedics Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Fri Jul 29, 10:11AM CDT
IRVINE, CA / ACCESSWIRE / July 29, 2016 / Khang & Khang LLP (the "Firm"
announces that a class action lawsuit was filed against Immunomedics Inc. ("Immunomedics" or the "Company" (NASDAQ: IMMU). Investors who purchased or otherwise acquired shares between April 20, 2016 and June 2, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the August 8, 2016, lead plaintiff motion deadline. IMMU: 2.65 (+0.04)
INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Immunomedics, Inc. of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 8, 2016
BusinessWire - Fri Jul 29, 8:35AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
IMMU: 2.65 (+0.04)
Brower Piven Alerts Shareholders of Upcoming Deadline in Class Action Lawsuit and Encourages Investors Who Have Losses in Excess of $100,000 From Investment in Immunomedics, Inc. to Contact the Firm - IMMU
GlobeNewswire - Thu Jul 28, 2:45PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Immunomedics, Inc. (Nasdaq:IMMU) ("Immunomedics" or the "Company"
securities during the period between April 20, 2016 and June 3, 2016, inclusive (the "Class Period". Investors with losses in excess of $100,000 who wish to become proactively involved in the litigation have until August 8, 2016 to seek appointment as lead plaintiff. IMMU: 2.65 (+0.04)
IMPORTANT SHAREHOLDER ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Immunomedics Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Tue Jul 26, 10:53AM CDT
LOS ANGELES, CA / ACCESSWIRE / July 26, 2016 / Lundin Law PC (the "Firm"
announces that a class action lawsuit was filed against Immunomedics Inc. ("Immunomedics" or the "Company" (NASDAQ: IMMU) concerning possible violations of federal securities laws between April 20, 2016 and June 2, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the August 8, 2016 lead plaintiff motion deadline. IMMU: 2.65 (+0.04)
DEADLINE ALERT - Bronstein, Gewirtz & Grossman, LLC Reminds Investors of a Class Action against Immunomedics Inc. (IMMU) and Lead Platintiff Deadline: August 8, 2016
ACCESSWIRE - Tue Jul 26, 9:24AM CDT
NEW YORK, NY / ACCESSWIRE / July 26, 2016 / Bronstein, Gewirtz & Grossman, LLC, reminds investors of class action against Immunomedics, Inc. ("Immunomedics" or the "Company"
(NASDAQ-GM: IMMU). The class action has been filed in the United States District Court, District of New Jersey, on behalf of a class consisting of all persons or entities who purchased Immunomedics common stock between April 20, 2016 and June 2, 2016 inclusive (the "Class Period". IMMU: 2.65 (+0.04)
SHAREHOLDER ALERT: The Law Offices of Vincent Wong Notifies Investors of Commencement of a Class Action Involving Immunomedics, Inc. and a Lead Plaintiff Deadline of August 8, 2016 - IMMU
BusinessWire - Mon Jul 25, 9:24AM CDT
The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of New Jersey on behalf of investors who purchased Immunomedics, Inc. (NASDAQ: IMMU) securities between April 20, 2016 and June 2, 2016.
IMMU: 2.65 (+0.04)
INVESTOR NOTICE: Khang & Khang LLP Announces Securities Class Action Lawsuit against Immunomedics Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Mon Jul 25, 4:49AM CDT
IRVINE, CA / ACCESSWIRE / July 25, 2016 / Khang & Khang LLP (the "Firm"
announces that a class action lawsuit was filed against Immunomedics Inc. ("Immunomedics" or the "Company" (NASDAQ: IMMU). Investors who purchased or otherwise acquired shares between April 20, 2016 and June 2, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the August 8, 2016, lead plaintiff motion deadline. IMMU: 2.65 (+0.04)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Immunomedics, Inc. of Class Action Lawsuit and Upcoming Deadline - IMMU
GlobeNewswire - Sun Jul 24, 8:00AM CDT
Pomerantz LLP announces that a class action lawsuit has been filed against Immunomedics, Inc. ("Immunomedics" or the "Company"
(NASDAQ:IMMU) and certain of its officers. The class action, filed in United States District Court, District of New Jersey, is on behalf of a class consisting of all persons or entities who purchased or otherwise acquired Immunomedics securities between April 20, 2016 and June 2, 2016 inclusive (the "Class Period". This class action seeks to recover damages against Defendants for alleged violations of the federal securities laws under the Securities Exchange Act of 1934 (the "Exchange Act". IMMU: 2.65 (+0.04)
EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Immunomedics, Inc. - IMMU
GlobeNewswire - Mon Jul 18, 5:33PM CDT
Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of Immunomedics, Inc. securities (NASDAQ:IMMU) from April 20, 2016 through June 2, 2016, both dates inclusive (the "Class Period"
. The lawsuit seeks to recover damages for Immunomedics investors under the federal securities laws. IMMU: 2.65 (+0.04)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Shareholders of Immunomedics, Inc. of Commencement of a Class Action Lawsuit and a Lead Plaintiff Deadline of August 8, 2016
BusinessWire - Fri Jul 15, 8:15AM CDT
The following statement is being issued by Levi & Korsinsky, LLP:
IMMU: 2.65 (+0.04)
IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces the Filing of a Securities Class Action Lawsuit against Immunomedics Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Thu Jul 14, 12:11PM CDT
IRVINE, CA / ACCESSWIRE / July 14, 2016 / Khang & Khang LLP (the "Firm"
announces that a class action lawsuit has been filed against Immunomedics Inc. ("Immunomedics" or the "Company" (NASDAQ: IMMU). Investors who purchased or otherwise acquired shares between April 20, 2016 and June 2, 2016 inclusive (the "Class Period", are encouraged to contact the Firm prior to the August 8, 2016 lead plaintiff motion deadline. IMMU: 2.65 (+0.04)
SHAREHOLDER ALERT - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of a Class Action against Immunomedics Inc. (IMMU) and Lead Platintiff Deadline August 8, 2016
ACCESSWIRE - Thu Jul 14, 9:20AM CDT
NEW YORK, NY / ACCESSWIRE / July 14, 2016 / Bronstein, Gewirtz & Grossman, LLC, notifies investors of a class action against Immunomedics, Inc. ("Immunomedics" or the "Company"
(NASDAQ-GM: IMMU). The class action has been filed in the United States District Court, District of New Jersey, on behalf of a class consisting of all persons or entities who purchased Immunomedics common stock between April 20, 2016 and June 2, 2016 inclusive (the "Class Period". IMMU: 2.65 (+0.04)
INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Immunomedics Inc. and Reminds Investors with Losses to Contact the Firm
ACCESSWIRE - Mon Jul 11, 12:16PM CDT
LOS ANGELES, CA / ACCESSWIRE / July 11, 2016 / Lundin Law PC announces a class action lawsuit has been filed against Immunomedics Inc. ("Immunomedics" or the "Company"
(NASDAQ: IMMU) concerning possible violations of federal securities laws between April 20, 2016 and June 3, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the August 8, 2016 lead plaintiff motion deadline. IMMU: 2.65 (+0.04)
IMMUNOMEDICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Immunomedics Inc. - IMMU
PR Newswire - Fri Jul 08, 9:07PM CDT
Kahn Swick & Foti, LLC ("KSF"
and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until August 8, 2016 to file lead plaintiff applications in a securities class action lawsuit against Immunomedics Inc. (NasdaqGM: IMMU), if they purchased the Company's securities between April 20, 2016 and June 2, 2016, inclusive (the "Class Period". This action is pending in the United States District Court for the District of New Jersey. IMMU: 2.65 (+0.04)
IMPORTANT SHAREHOLDER NOTICE: Lundin Law PC Announces Securities Class Action Lawsuit Against Immunomedics Inc. And Reminds Investors With Losses To Contact The Firm
ACCESSWIRE - Thu Jul 07, 7:55PM CDT
LOS ANGELES, CA / ACCESSWIRE / July 7, 2016 / Lundin Law PC announces a class action lawsuit has been filed against Immunomedics Inc. ("Immunomedics" or the "Company"
(Nasdaq: IMMU) concerning possible violations of federal securities laws between April 20, 2016 and June 3, 2016 (the "Class Period". Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the August 8, 2016 lead plaintiff motion deadline. IMMU: 2.65 (+0.04)
SHAREHOLDER ALERT: Rosen Law Firm Reminds Immunomedics, Inc. Investors of Important Deadline in Class Action - IMMU
BusinessWire - Thu Jun 23, 2:34PM CDT
Rosen Law Firm, a global investor rights law firm, reminds purchasers of Immunomedics, Inc. securities (NASDAQ:IMMU) from April 20, 2016 through June 2, 2016, both dates inclusive (the "Class Period"
of the important August 8, 2016 lead plaintiff deadline in the class action. The lawsuit seeks to recover damages for Immunomedics investors under the federal securities laws. IMMU: 2.65 (+0.04)
DEADLINE ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Immunomedics Inc. and Reminds Investors with Losses to Contact the Firm
BusinessWire - Thu Jun 23, 4:30AM CDT
Lundin Law PC announces a class action lawsuit has been filed against Immunomedics Inc. ("Immunomedics" or the "Company"
(Nasdaq: IMMU) concerning possible violations of federal securities laws between April 20, 2016 and June 3, 2016. Investors who purchased or otherwise acquired shares during the Class Period should contact the Firm in advance of the August 8, 2016, lead plaintiff motion deadline. IMMU: 2.65 (+0.04)
IMMUNOMEDICS, INC. INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit
BusinessWire - Mon Jun 20, 4:52PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of purchasers of Immunomedics, Inc. (Nasdaq: IMMU) ("Immunomedics" or the "Company"
securities during the period between April 20, 2016 and June 3, 2016, inclusive (the "Class Period". Investors with losses in excess of $100,000 who wish to become proactively involved in the litigation have until August 8, 2016 to seek appointment as lead plaintiff. IMMU: 2.65 (+0.04)
